---
title: "Biology Pathology of mantle cell lymphoma"
slug: "biology-pathology-of-mantle-cell-lymphoma"
date: "2023-06-06"
enableToc: false
tags:
- building
---

> [!info]
>
> ğŸŒ± ä¾†è‡ª: [[mantle cell lymphoma]]

# Biology Pathology of mantle cell lymphoma

## MCLçš„èµ·æºæ˜¯å“ªç¨®Bç´°èƒï¼Ÿ
- æ‘˜è¦ï¼š
MCLé€šå¸¸ä»¥å°æ·‹å·´ç´°èƒæµ¸æ½¤å’Œå‡¹é™·æ ¸ç‚ºä¸»è¦çµ„ç¹”ç‰¹å¾µï¼Œèµ·æºæ–¼æˆç†Ÿã€å¹¼ç¨šæˆ–å¾Œèƒšç´°èƒä¸­å¿ƒBç´°èƒã€‚
- åŸæ–‡ï¼š
Derived from a mature, naÃ¯ve or postgerminal **center B-cell**. MCL most often presents histologically as an infiltrate of small lymphocytes w/ notched nuclei.

## è«‹å•æ·‹å·´ç˜¤æœ‰å“ªäº›çµ„ç¹”å­¸è®Šç•°å‹æ…‹ï¼Ÿ
- æ‘˜è¦ï¼š
æ·‹å·´ç˜¤æœ‰å¤šç¨®çµ„ç¹”å­¸è®Šç•°å‹æ…‹ï¼ŒåŒ…æ‹¬é å¾Œè¼ƒå·®çš„çˆ†ç™¼å‹å’Œå¤šå½¢æ€§å‹ï¼Œä»¥åŠå½¢æ…‹é¡ä¼¼æ–¼CLL/SLLçš„å°ç´°èƒå‹ã€‚
- åŸæ–‡ï¼š
Several histologic variants include the **blastoid & pleomorphic** variants w/c have a poor prognosis & small cell variant w/c is morphologically similar to CLL/SLL.

## é€™ç¨®lymphomaé€šå¸¸è¡¨é”å“ªäº›ç´°èƒè¡¨é¢æŠ—åŸï¼Ÿ
- æ‘˜è¦ï¼šé€™ç¨®lymphomaé€šå¸¸è¡¨é”Bç´°èƒæŠ—åŸï¼ˆ**CD19å’ŒCD20**ï¼‰å’ŒTç´°èƒæŠ—åŸCD5ï¼ˆç•°å¸¸è¡¨é”ï¼Œä¹Ÿå¯è¦‹æ–¼CLL / SLLï¼‰ï¼Œä½†**ä¸è¡¨é”CD10ï¼ˆFLï¼‰**ï¼ŒCD23ï¼ˆCLLï¼‰æˆ–CD200ï¼ˆCLLï¼‰ã€‚
- åŸæ–‡ï¼šTypically expresses B-cell Ags (CD19 & CD20) & the T-cell Ag CD5 (aberrant expression, also seen in CLL/SLL), but not CD10 (FL), CD23 (CLL), or CD200 (CLL)ã€‚

## ä»€éº¼æ˜¯t(11;14)(q13;q32)ï¼Ÿ
- æ‘˜è¦ï¼št(11;14)(q13;q32)æ˜¯ä¸€ç¨®ç´°èƒéºå‚³ç•°å¸¸ï¼Œå®ƒä½¿å¾—Cyclin D1åŸºå› (CCDN1)å’ŒIgé‡éˆåŸºå› å®šä½åœ¨ä¸€èµ·ï¼Œå¯ä»¥é€šéFISHï¼Œæ ¸å‹åˆ†ææˆ–IHC(=BCL1æŸ“è‰²)é€²è¡Œæª¢æ¸¬ã€‚
- åŸæ–‡ï¼šThe hallmark cytogenetic abnormality is the t(11;14)(q13;q32). It juxtaposes the Cyclin D1 gene (CCDN1) w/ the Ig heavy chain locus detectable by FISH, karyotype, or IHC (= BCL1 stain)
-
## ä»€éº¼æ˜¯ç½•è¦‹çš„CCND1(â€“)ç—…ä¾‹ï¼Ÿ
- æ‘˜è¦ï¼šç½•è¦‹çš„CCND1(â€“)ç—…ä¾‹å…·æœ‰SOX11(+)å’ŒCyclin D2æˆ–D3ç—…è®Šï¼Œå¿…é ˆèˆ‡CD23(â€“) CLLå’ŒCD5(+) MZLå€åˆ†é–‹ä¾†ã€‚
- åŸæ–‡ï¼šRare CCND1(â€“) cases are SOX11(+) & have Cyclin D2 or D3 lesions. Must be distinguished from CD23(â€“) CLL & CD5(+) MZL.

## é€™ç¨®æ·‹å·´ç˜¤çš„è‡¨åºŠè¡¨ç¾æ˜¯ä»€éº¼ï¼Ÿ
- æ‘˜è¦ï¼šé€™ç¨®æ·‹å·´ç˜¤çš„è‡¨åºŠè¡¨ç¾ä»‹æ–¼æ…¢æ€§å’Œä¾µçŠ¯æ€§ä¹‹é–“ã€‚
- åŸæ–‡ï¼šClinical behavior is intermediate between indolent & aggressive lymphomas.

- Proliferative index measured by Ki-67 (â‰¥30% vs. <30%) (Ann Oncol 2010;21:133), p53 abnormality (del17p or TP53 Mt), & SOX11 expression are powerful prognostic factors in MCL & predict for aggressive disease
- Some cases w/ spleen/BM or GIT involvement may have an indolent behavior, typically SOX11âˆ’
